Emergent BioSolutions EBS reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Emergent BioSolutions missed estimated earnings by 155.65%, reporting an EPS of $-3.17 versus an estimate of $-1.24.
Revenue was down $142.40 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.35 which was followed by a 11.57% drop in the share price the next day.
Here's a look at Emergent BioSolutions's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | 0.04 | -0.06 | 0.37 | 0.12 |
EPS Actual | -0.31 | -1.27 | -0.86 | 0.18 |
Revenue Estimate | 296.62M | 268.30M | 270.94M | 283.00M |
Revenue Actual | 330.70M | 240.00M | 242.70M | 307.50M |
To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.